Marjut Kauppila
Turku, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Journal: European journal of haematology
Published: February 27, 2022
Thromboembolism prophylaxis in patients with Philadelphia-negative myeloproliferative neoplasms-Clinical practice among Nordic specialists.
Journal: European journal of haematology
Published: February 05, 2018
Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.
Journal: Infectious diseases (London, England)
Published: July 08, 2017
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.
Journal: Journal of clinical apheresis
Published: May 04, 2017
Platelet donor selection for HLA-immunised patients; the impact of donor-specific HLA antibody levels.
Journal: Transfusion medicine (Oxford, England)
Published: September 28, 2016
Treatment of adult acute myeloid leukemia.
Journal: Duodecim; laaketieteellinen aikakauskirja
Published: January 01, 2016
Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma.
Journal: Bone marrow transplantation
Published: October 14, 2014
Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS
Journal: Duodecim; laaketieteellinen aikakauskirja
Published: April 30, 2014
Stem cell transplantation in myelofibrosis
Journal: Duodecim; laaketieteellinen aikakauskirja
Published: January 14, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026